What does Docteur Franck Pieron Médical do?

Docteur Franck Pieron Médical is a specialist medical practice in Sprimont. Private Limited, started on 28 June 2006.

What is the address of Docteur Franck Pieron Médical?

The registered office of Docteur Franck Pieron Médical is located at Rue de Beauval 12, 4140 Sprimont.

Is Docteur Franck Pieron Médical still active?

Yes. According to the CBE (29 September 2026) Docteur Franck Pieron Médical is active, legal situation “Normale toestand”, started on 28 June 2006.

Is Docteur Franck Pieron Médical registered on Peppol?

Yes, Docteur Franck Pieron Médical is registered on the Peppol network with ID 0208:0882140269.

What is the enterprise number of Docteur Franck Pieron Médical?

The enterprise number of Docteur Franck Pieron Médical is BE0882140269.

When was Docteur Franck Pieron Médical founded?

Docteur Franck Pieron Médical was founded on 28 June 2006.

Who are the directors of Docteur Franck Pieron Médical?

According to the 2025 annual accounts, the directors of Docteur Franck Pieron Médical are: Franck PIERON.

Is Docteur Franck Pieron Médical a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 June 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Docteur Franck Pieron Médical make in 2025?

Docteur Franck Pieron Médical posted a profit after taxes of € 113,116 in financial year 2025.

What is the revenue of Docteur Franck Pieron Médical?

As a small company, Docteur Franck Pieron Médical is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 186,610.

Docteur Franck Pieron Médical (Private Limited)

Dossier Docteur Franck Pieron Médical, printed on 29 September 2026 from databakkes.be/en/0882140269/docteur-franck-pieron-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Docteur Franck Pieron Médical from Sprimont, company number BE0882140269, closed financial year 2025 with a result of € 113,116 after tax. For that financial year Docteur Franck Pieron Médical recorded a gross margin of € 186,610 and equity of € 370,716. Compared with financial year 2024, the result moved from € 109,938 to € 113,116. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 370,716

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 113,116

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 15,312

▼ 75% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 94,131 paid out

83 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 43,175

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 27,473

▼ 50% vs 2024

€ 15,542 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 4,092

▲ 146% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,700

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 150,696 Gross margin 2022: € 150,696 First fiscal year in the series	€ 161,355 Gross margin 2023: € 161,355 ▲ 7% vs 2022 (€ 150,696) Favourable step	€ 188,042 Gross margin 2024: € 188,042 ▲ 17% vs 2023 (€ 161,355) Favourable step	€ 186,610 Gross margin 2025: € 186,610 ▼ 1% vs 2024 (€ 188,042) Unfavourable step	▼ 1%
Profit after taxes	€ 76,042 Profit after taxes 2022: € 76,042 First fiscal year in the series	€ 101,620 Profit after taxes 2023: € 101,620 ▲ 34% vs 2022 (€ 76,042) Favourable step	€ 109,938 Profit after taxes 2024: € 109,938 ▲ 8% vs 2023 (€ 101,620) Favourable step	€ 113,116 Profit after taxes 2025: € 113,116 ▲ 3% vs 2024 (€ 109,938) Favourable step	▲ 3%
Equity	€ 186,170 Equity 2022: € 186,170 First fiscal year in the series	€ 287,790 Equity 2023: € 287,790 ▲ 55% vs 2022 (€ 186,170) Favourable step	€ 351,731 Equity 2024: € 351,731 ▲ 22% vs 2023 (€ 287,790) Favourable step	€ 370,716 Equity 2025: € 370,716 ▲ 5% vs 2024 (€ 351,731) Favourable step	▲ 5%
Total debts	€ 111,638 Total debts 2022: € 111,638 First fiscal year in the series	€ 96,883 Total debts 2023: € 96,883 ▼ 13% vs 2022 (€ 111,638) Favourable step	€ 59,024 Total debts 2024: € 59,024 ▼ 39% vs 2023 (€ 96,883) Favourable step	€ 34,265 Total debts 2025: € 34,265 ▼ 42% vs 2024 (€ 59,024) Favourable step	▼ 42%
Cash	€ 67,277 Cash 2022: € 67,277 First fiscal year in the series	€ 58,495 Cash 2023: € 58,495 ▼ 13% vs 2022 (€ 67,277) Unfavourable step	€ 60,636 Cash 2024: € 60,636 ▲ 4% vs 2023 (€ 58,495) Favourable step	€ 15,312 Cash 2025: € 15,312 ▼ 75% vs 2024 (€ 60,636) Unfavourable step	▼ 75%
Land & buildings	€ 2,070 Land & buildings 2022: € 2,070 First fiscal year in the series	€ 79,910 Land & buildings 2023: € 79,910 ▲ € 77,840 vs 2022 (€ 2,070) Unchanged	€ 67,169 Land & buildings 2024: € 67,169 ▼ 16% vs 2023 (€ 79,910) Unchanged	€ 54,427 Land & buildings 2025: € 54,427 ▼ 19% vs 2024 (€ 67,169) Unchanged	▼ 19%
Retained profit	€ 186,170 Retained profit 2022: € 186,170 First fiscal year in the series	€ 287,790 Retained profit 2023: € 287,790 ▲ 55% vs 2022 (€ 186,170) Favourable step	€ 351,731 Retained profit 2024: € 351,731 ▲ 22% vs 2023 (€ 287,790) Favourable step	€ 370,716 Retained profit 2025: € 370,716 ▲ 5% vs 2024 (€ 351,731) Favourable step	▲ 5%
Dividend	€ 30,000 Dividend 2022: € 30,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 30,000) Unchanged	€ 45,997 Dividend 2024: € 45,997 Unchanged (€ 0) Unchanged	€ 94,131 Dividend 2025: € 94,131 ▲ 105% vs 2024 (€ 45,997) Unchanged	▲ 105%
Bank debt	€ 54,350 Bank debt 2022: € 54,350 First fiscal year in the series	€ 81,064 Bank debt 2023: € 81,064 ▲ 49% vs 2022 (€ 54,350) Unfavourable step	€ 54,623 Bank debt 2024: € 54,623 ▼ 33% vs 2023 (€ 81,064) Favourable step	€ 27,473 Bank debt 2025: € 27,473 ▼ 50% vs 2024 (€ 54,623) Favourable step	▼ 50%
Balance sheet total	€ 297,808 Balance sheet total 2022: € 297,808 First fiscal year in the series	€ 384,673 Balance sheet total 2023: € 384,673 ▲ 29% vs 2022 (€ 297,808) Unchanged	€ 410,755 Balance sheet total 2024: € 410,755 ▲ 7% vs 2023 (€ 384,673) Unchanged	€ 404,980 Balance sheet total 2025: € 404,980 ▼ 1% vs 2024 (€ 410,755) Unchanged	▼ 1%

Key figures of Docteur Franck Pieron Médical, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Docteur Franck Pieron Médical?

What happened at Docteur Franck Pieron Médical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 113,116 (▲ 3% vs 2024). filed late Source: NBB ↗
Jun 28, 2006 Start of the company according to the CBE. KBO
2006 Franck PIERON became a director. NBB

In short

From € 76,042 profit in 2022 to € 113,116 profit in 2025.

Paid € 162,227 in corporate taxes since 2022.

Best year ever: 2025, with € 113,116 profit.

Paid out € 170,128 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Docteur Franck Pieron Médical? We notify you, reason included.

Follow Docteur Franck Pieron Médical

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit